Proactiveinvestors recommends
Additional Information
Market: AIM
Sector: Software & Computer Services
EPIC: AVIA
Latest Price: 8.63p  (0,00%)
52-week High: 45.25p
52-week Low: 5.75p
Market Cap: 0.55M
1 year chart
digital-look imported chart image
1 day chart
digital-look imported chart image
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
Avia Health Informatics
www.ahi-plc.com/index.html

 

Avia Health Informatics Plc ("Avia") was incorporated in the UK, which is also its main country of operation.

Avia, via its trading subsidiary Plain Healthcare Limited ("Plain"), develops, supports and maintains the Odyssey clinical decision support software products and systems.

The Odyssey software product range is for use by clinicians and non-clinicians in healthcare and non-healthcare markets in the UK and internationally.

 

Full Avia Health Informatics profile here
Is AVIA a Buy, Sell or Hold?Get your FREE analysis of AVIA
Pdf

Avia Health Informatics wins order for PathFinderRF product

10th Jan 2012, 7:59 am by Andre Lamberti Avia won an order for PathFinderRF, an on-line referral decision support and clinical communication system that enables commissioning groups and other primary care organisations to manage referral decision-making and the communication of clinical information

Clinical decision support systems maker Avia Health Informatics (LON:AVIA) said its unit Plain Healthcare has signed a contract for the sale of PathFinderRF software to the Lincolnshire South West Clinical Commissioning Group.

Financial details for the deal were not disclosed.

PathFinderRF is an on-line referral decision support and clinical communication system that enables commissioning groups and other primary care organisations to manage referral decision-making and the communication of clinical information from general practice to specialist and community services.

Avia acquired the intellectual property rights to sell and manage development of PathFinderRF from Nene Commissioning Group in June last year.

With its existing Odyssey clinical decision support systems and now PathFinderRF, Avia can now offer healthcare organisations across the UK and Ireland various clinical 'end-to-end' products to help improve the efficiency of their services.

The product range for primary care now spans initial self-assessment using Odyssey SelfAssess; receptionist prioritisation and assessment by the clinician using Odyssey PatientAssess; and the referral by the clinician to community or specialist care using PathFinderRF.

Yesterday, Avia launched a new remote or cloud-hosted version of Odyssey CareAssess for use by care homes.

Having Odyssey CareAssess delivered by a cloud hosting partner means that homes that could not afford the initial capital outlay can now access the software through 3G or broadband on a pay as you go and/or monthly subscription basis.

The Odyssey range is built on a common medical content database which has been developed over the past 16 years and is tailored for prisons, ships, call centres, GP out of hours, walk in centres, care homes, pharmacies and other clinical and non-clinical environments.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.